Insider Trading › ARWR › Insiders
ARROWHEAD PHARMACEUTICALS, INC.
ARWR·Nasdaq·
United States·Insider activity
United States·Insider activity$61.54
-0.81 (-1.30%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
ARWR
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ARWRS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, ARWR insiders filed 0 purchases ($0) and 7 sales ($3.1M) on the open market, by 5 insiders. Newest filing Aug 20, 2026 (1 month ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by ARWR insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$3.1MSales · 180 days
472Open-market transactions on record
5Insiders filing · 180 days
Purchases (code P) and sales (code S) of ARWR common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
472 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| PERRY MICHAEL SDirector · Director | Sale | −11.6K | $87.30 | $1.0M | 111.5Kdirect | Aug 18, 2026 | Aug 20, 2026 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector · Director | Sale | −2,000 | $86.96 | $174K | 31.6Kdirect | Aug 18, 2026 | Aug 20, 2026 | Form 4 ↗ |
| Lu HongboDirector | Sale | −2,970 | $76.88 | $228K | 52.0Kdirect | May 12, 2026 | May 14, 2026 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −10.0K | $75.00 | $750K | 227.0Kdirect | Apr 23, 2026 | Apr 24, 2026 | Form 4 ↗ |
| Apel Daniel JosephChief Financial Officer | Sale | −8,730 | $71.92 | $628K | 162.9Kdirect | Apr 22, 2026 | Apr 24, 2026 | Form 4 ↗ |
| Apel Daniel JosephChief Financial Officer | Sale | −1,157 | $70.45 | $82K | 171.6Kdirect | Apr 22, 2026 | Apr 24, 2026 | Form 4 ↗ |
| Apel Daniel JosephChief Financial Officer | Sale | −3,208 | $70.11 | $225K | 172.8Kdirect | Apr 22, 2026 | Apr 24, 2026 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −10.0K | $64.19 | $642K | 237.0Kdirect | Mar 5, 2026 | Mar 9, 2026 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −309 | $68.00 | $21K | 172.0Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −437 | $65.97 | $29K | 172.3Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −1,200 | $64.49 | $77K | 172.7Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −12.7K | $63.95 | $813K | 173.9Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −14.8K | $63.01 | $932K | 186.6Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −6,090 | $62.28 | $379K | 201.4Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −4,625 | $61.24 | $283K | 207.5Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −46 | $68.00 | $3K | 474.9Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −2,336 | $64.04 | $150K | 475.0Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −5,873 | $62.91 | $369K | 477.3Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −900 | $62.25 | $56K | 483.2Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −600 | $61.12 | $37K | 484.1Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −313 | $68.00 | $21K | 484.7Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −900 | $66.01 | $59K | 485.0Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −2,700 | $64.44 | $174K | 485.9Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −11.8K | $63.84 | $756K | 488.6Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −13.5K | $62.96 | $847K | 500.4Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −6,164 | $62.23 | $384K | 513.9Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| O'Brien PatrickCOO | Sale | −4,368 | $61.20 | $267K | 520.0Kdirect | Jan 5, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −5,771 | $66.39 | $383K | 3.8Mdirect | Jan 2, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −7,416 | $65.88 | $489K | 3.8Mdirect | Jan 2, 2026 | Jan 5, 2026 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −16.5K | $68.69 | $1.1M | 3.8Mdirect | Dec 29, 2025 | Dec 30, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −35.2K | $69.33 | $2.4M | 3.8Mdirect | Dec 29, 2025 | Dec 30, 2025 | Form 4 ↗ |
| Ferrari MauroDirector | Sale | −7,530 | $70.00 | $527K | 69.1Kdirect | Dec 26, 2025 | Dec 30, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −2,574 | $68.85 | $177K | 3.8Mdirect | Dec 22, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −10.0K | $68.33 | $684K | 3.8Mdirect | Dec 22, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Vakiener VictoriaDirector | Sale | −1,960 | $68.39 | $134K | 35.7Kdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Vakiener VictoriaDirector | Sale | −5,281 | $67.97 | $359K | 37.7Kdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Vakiener VictoriaDirector | Sale | −2,799 | $66.63 | $186K | 43.0Kdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Waddill William D.Director | Sale | −500 | $68.53 | $34K | 56.6Kdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Waddill William D.Director | Sale | −5,451 | $68.01 | $371K | 57.1Kdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Waddill William D.Director | Sale | −2,416 | $66.66 | $161K | 62.5Kdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −1,319 | $68.48 | $90K | 3.8Mdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −8,147 | $68.01 | $554K | 3.8Mdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −3,979 | $66.67 | $265K | 3.8Mdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −827 | $68.48 | $57K | 33.6Kdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −6,083 | $68.04 | $414K | 34.4Kdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −3,090 | $66.70 | $206K | 40.5Kdirect | Dec 19, 2025 | Dec 23, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −1,981 | $66.30 | $131K | 3.8Mdirect | Dec 17, 2025 | Dec 19, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −982 | $65.53 | $64K | 3.8Mdirect | Dec 17, 2025 | Dec 19, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −35.8K | $64.51 | $2.3M | 3.8Mdirect | Dec 17, 2025 | Dec 19, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −46.3K | $63.55 | $2.9M | 3.9Mdirect | Dec 17, 2025 | Dec 19, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −3,221 | $67.87 | $219K | 3.9Mdirect | Dec 16, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −166 | $66.77 | $11K | 3.9Mdirect | Dec 16, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −1,300 | $65.77 | $86K | 3.9Mdirect | Dec 16, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −1,000 | $64.96 | $65K | 3.9Mdirect | Dec 16, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −6,661 | $64.29 | $428K | 3.9Mdirect | Dec 16, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −8,476 | $62.94 | $533K | 3.9Mdirect | Dec 16, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −14.1K | $62.12 | $876K | 3.9Mdirect | Dec 16, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −11.0K | $61.25 | $671K | 4.0Mdirect | Dec 16, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −8,416 | $60.51 | $509K | 4.0Mdirect | Dec 16, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −8,147 | $69.96 | $570K | 4.0Mdirect | Dec 15, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −21.3K | $69.28 | $1.5M | 4.0Mdirect | Dec 15, 2025 | Dec 16, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −100.5K | $68.67 | $6.9M | 4.0Mdirect | Dec 15, 2025 | Dec 16, 2025 | Form 4 ↗ |
| PERRY MICHAEL SDirector | Sale | −16.3K | $61.03 | $992K | 115.2Kdirect | Dec 5, 2025 | Dec 9, 2025 | Form 4 ↗ |
| Ferrari MauroDirector | Sale | −8,750 | $56.39 | $493K | 68.8Kdirect | Nov 28, 2025 | Dec 1, 2025 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −20.0K | $35.00 | $700K | 212.1Kdirect | Oct 1, 2025 | Oct 3, 2025 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −15.0K | $30.00 | $450K | 232.1Kdirect | Sep 12, 2025 | Sep 16, 2025 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −15.0K | $25.00 | $375K | 247.1Kdirect | Sep 2, 2025 | Sep 4, 2025 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −9,389 | $20.00 | $188K | 262.1Kdirect | Aug 15, 2025 | Aug 15, 2025 | Form 4 ↗ |
| Hamilton James CChief Medical Officer | Sale | −611 | $20.00 | $12K | 271.5Kdirect | Aug 13, 2025 | Aug 15, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −50.8K | $11.49 | $584K | 3.9Mdirect | Apr 11, 2025 | Apr 11, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −50.0K | $10.87 | $544K | 4.0Mdirect | Apr 10, 2025 | Apr 11, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −1,617 | $11.76 | $19K | 4.0Mdirect | Apr 9, 2025 | Apr 11, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −3,400 | $10.75 | $37K | 4.0Mdirect | Apr 9, 2025 | Apr 11, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −35.3K | $9.93 | $351K | 4.0Mdirect | Apr 9, 2025 | Apr 11, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −51.4K | $15.07 | $775K | 4.1Mdirect | Mar 13, 2025 | Mar 17, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −133.3K | $17.02 | $2.3M | 3.8Mdirect | Mar 4, 2025 | Mar 5, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −166.7K | $18.03 | $3.0M | 3.9Mdirect | Mar 3, 2025 | Mar 5, 2025 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −959 | $21.00 | $20K | 35.8Kdirect | Jan 23, 2025 | Jan 27, 2025 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −8,000 | $19.69 | $158K | 527.2Kdirect | Jan 7, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −10.0K | $19.69 | $197K | 455.4Kdirect | Jan 7, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −8,000 | $19.70 | $158K | 465.4Kdirect | Jan 7, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Hamilton James CChief Discovery/Trans Medicine | Sale | −11.0K | $20.11 | $221K | 272.1Kdirect | Jan 6, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Hamilton James CChief Discovery/Trans Medicine | Sale | −21.8K | $19.68 | $428K | 283.1Kdirect | Jan 6, 2025 | Jan 7, 2025 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −9,526 | $20.10 | $191K | 535.2Kdirect | Jan 6, 2025 | Jan 7, 2025 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −19.7K | $19.69 | $387K | 544.7Kdirect | Jan 6, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −9,402 | $20.10 | $189K | 473.4Kdirect | Jan 6, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −17.8K | $19.68 | $350K | 482.8Kdirect | Jan 6, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −11.5K | $19.05 | $219K | 3.8Mdirect | Jan 2, 2025 | Jan 6, 2025 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −2,850 | $20.00 | $57K | 36.7Kdirect | Dec 27, 2024 | Dec 30, 2024 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −12.6K | $19.59 | $246K | 3.8Mdirect | Dec 23, 2024 | Dec 23, 2024 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −5,799 | $22.12 | $128K | 3.7Mdirect | Dec 18, 2024 | Dec 20, 2024 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −8,260 | $21.74 | $180K | 3.7Mdirect | Dec 18, 2024 | Dec 20, 2024 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −12.7K | $20.52 | $260K | 3.7Mdirect | Dec 18, 2024 | Dec 20, 2024 | Form 4 ↗ |
| Waddill William D.Director | Sale | −3,747 | $22.04 | $83K | 40.4Kdirect | Dec 17, 2024 | Dec 18, 2024 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −547 | $22.04 | $12K | 124.2Kdirect | Dec 17, 2024 | Dec 18, 2024 | Form 4 ↗ |
| Waddill William D.Director | Sale | −3,748 | $21.90 | $82K | 44.1Kdirect | Dec 16, 2024 | Dec 18, 2024 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −5,000 | $21.90 | $110K | 124.7Kdirect | Dec 16, 2024 | Dec 18, 2024 | Form 4 ↗ |
| Vakiener VictoriaDirector | Sale | −8,994 | $21.91 | $197K | 21.2Kdirect | Dec 16, 2024 | Dec 18, 2024 | Form 4 ↗ |
| Oliver TracieChief Commercial Officer | Sale | −9,394 | $25.28 | $237K | 127.1Kdirect | Jul 2, 2024 | Jul 3, 2024 | Form 4 ↗ |
| Vakiener VictoriaDirector | Sale | −1,799 | $23.31 | $42K | 30.2Kdirect | May 2, 2024 | May 6, 2024 | Form 4 ↗ |
| Lu HongboDirector | Purchase | +500 | $22.00 | $11K | 36.1Kdirect | Apr 18, 2024 | Nov 15, 2024 | Form 4 ↗ |
| Lu HongboDirector | Purchase | +500 | $25.00 | $13K | 35.6Kdirect | Apr 10, 2024 | Nov 15, 2024 | Form 4 ↗ |
| Lu HongboDirector | Purchase | +150 | $27.34 | $4K | 35.1Kdirect | Apr 2, 2024 | Nov 15, 2024 | Form 4 ↗ |
| Hamilton James CChief Discovery/Trans Medicine | Sale | −6,000 | $28.03 | $168K | 204.9Kdirect | Apr 1, 2024 | Apr 3, 2024 | Form 4 ↗ |
| Lu HongboDirector | Purchase | +850 | $27.50 | $23K | 34.9Kdirect | Mar 26, 2024 | Nov 15, 2024 | Form 4 ↗ |
| Lu HongboDirector | Purchase | +400 | $28.00 | $11K | 34.1Kdirect | Mar 22, 2024 | Nov 15, 2024 | Form 4 ↗ |
| Lu HongboDirector | Purchase | +1,000 | $27.50 | $28K | 33.7Kdirect | Mar 20, 2024 | Mar 20, 2024 | Form 4 ↗ |
| Lu HongboDirector | Purchase | +1,000 | $28.00 | $28K | 32.7Kdirect | Mar 19, 2024 | Mar 20, 2024 | Form 4 ↗ |
| Lu HongboDirector | Purchase | +1,000 | $27.49 | $27K | 31.7Kdirect | Mar 18, 2024 | Mar 20, 2024 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −40.0K | $35.19 | $1.4M | 400.6Kdirect | Mar 6, 2024 | Mar 8, 2024 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −19.7K | $32.71 | $645K | 3.7Mdirect | Jan 31, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −37.8K | $32.16 | $1.2M | 3.7Mdirect | Jan 31, 2024 | Feb 2, 2024 | Form 4 ↗ |
| Hamilton James CChief Discovery/Trans Medicine | Sale | −3,702 | $37.37 | $138K | 210.9Kdirect | Jan 12, 2024 | Jan 17, 2024 | Form 4 ↗ |
| Hamilton James CChief Discovery/Trans Medicine | Sale | −4,238 | $36.47 | $155K | 214.6Kdirect | Jan 12, 2024 | Jan 17, 2024 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −1,100 | $38.55 | $42K | 129.7Kdirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −1,811 | $37.76 | $68K | 130.8Kdirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Waddill William D.Director | Sale | −1,300 | $38.59 | $50K | 47.9Kdirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Waddill William D.Director | Sale | −2,634 | $37.81 | $100K | 49.2Kdirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Ferrari MauroDirector | Sale | −1,000 | $38.63 | $39K | 60.8Kdirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Ferrari MauroDirector | Sale | −2,147 | $37.80 | $81K | 61.8Kdirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Vakiener VictoriaDirector | Sale | −1,100 | $38.84 | $43K | 32.0Kdirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Vakiener VictoriaDirector | Sale | −3,620 | $37.87 | $137K | 33.1Kdirect | Jan 11, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Oliver TracieChief Commercial Officer | Sale | −74 | $33.89 | $3K | 136.5Kdirect | Jan 5, 2024 | Jan 8, 2024 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −8,904 | $35.65 | $317K | 440.6Kdirect | Jan 5, 2024 | Jan 8, 2024 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −5,800 | $34.97 | $203K | 449.5Kdirect | Jan 5, 2024 | Jan 8, 2024 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −1,400 | $34.04 | $48K | 455.3Kdirect | Jan 5, 2024 | Jan 8, 2024 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −4,403 | $35.64 | $157K | 198.5Kdirect | Jan 5, 2024 | Jan 8, 2024 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −3,100 | $35.03 | $109K | 202.9Kdirect | Jan 5, 2024 | Jan 8, 2024 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −800 | $34.11 | $27K | 206.0Kdirect | Jan 5, 2024 | Jan 8, 2024 | Form 4 ↗ |
| Hamilton James C | Sale | −10.0K | $35.00 | $350K | 218.8Kdirect | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Hamilton James C | Sale | −12.3K | $35.65 | $440K | 228.8Kdirect | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Hamilton James C | Sale | −8,000 | $34.94 | $280K | 241.1Kdirect | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Hamilton James C | Sale | −1,800 | $34.00 | $61K | 249.1Kdirect | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −12.7K | $35.65 | $454K | 464.4Kdirect | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −8,200 | $34.99 | $287K | 477.1Kdirect | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −1,900 | $33.99 | $65K | 485.3Kdirect | Jan 5, 2024 | Jan 5, 2024 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −1,600 | $32.63 | $52K | 402.2Kdirect | Jan 4, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Hamilton James C | Sale | −500 | $33.30 | $17K | 175.9Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Hamilton James C | Sale | −2,300 | $32.52 | $75K | 176.4Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Hamilton James C | Sale | −3,500 | $31.81 | $111K | 178.7Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −1,700 | $32.65 | $56K | 403.8Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −400 | $33.41 | $13K | 405.5Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −2,800 | $32.52 | $91K | 405.9Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −3,849 | $31.83 | $123K | 408.7Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −5,318 | $31.25 | $166K | 3.7Mdirect | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −4,634 | $30.74 | $142K | 3.7Mdirect | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −12.0K | $28.54 | $342K | 3.7Mdirect | Dec 20, 2023 | Dec 22, 2023 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −4,942 | $29.00 | $143K | 131.8Kdirect | Nov 20, 2023 | Nov 22, 2023 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −14.8K | $28.73 | $424K | 136.7Kdirect | Nov 20, 2023 | Nov 22, 2023 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −24.3K | $24.21 | $589K | 3.7Mdirect | Oct 25, 2023 | Oct 27, 2023 | Form 4 ↗ |
| Vakiener VictoriaDirector | Sale | −1,550 | $26.33 | $41K | 21.7Kdirect | Sep 28, 2023 | Oct 2, 2023 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −26.2K | $28.27 | $742K | 3.8Mdirect | Sep 18, 2023 | Sep 20, 2023 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −31.5K | $28.00 | $883K | 3.8Mdirect | Sep 18, 2023 | Sep 20, 2023 | Form 4 ↗ |
| Oliver TracieChief Commercial Officer | Sale | −8,925 | $35.31 | $315K | 61.6Kdirect | Jul 3, 2023 | Jul 6, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −3,000 | $35.53 | $107K | 188.5Kdirect | Jun 30, 2023 | Jul 5, 2023 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −15.0K | $36.20 | $543K | 381.7Kdirect | Jun 27, 2023 | Jun 29, 2023 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −6,500 | $40.90 | $266K | 117.6Kdirect | May 5, 2023 | May 8, 2023 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −26.0K | $40.02 | $1.0M | 3.8Mdirect | May 4, 2023 | May 5, 2023 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −24.0K | $38.97 | $936K | 3.8Mdirect | May 4, 2023 | May 5, 2023 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −54.9K | $39.14 | $2.1M | 3.8Mdirect | May 3, 2023 | May 5, 2023 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −11.3K | $32.65 | $371K | 7,867direct | Mar 3, 2023 | Mar 6, 2023 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −875 | $32.62 | $29K | 13.0Kindirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Waddill William D.Director | Sale | −3,200 | $30.00 | $96K | 28.9Kdirect | Jan 9, 2023 | Jan 11, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −7,500 | $37.39 | $280K | 413.4Kdirect | Jan 5, 2023 | Jan 6, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −7,500 | $37.39 | $280K | 420.9Kdirect | Jan 5, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −6,573 | $37.40 | $246K | 191.5Kdirect | Jan 5, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −7,230 | $37.40 | $270K | 198.1Kdirect | Jan 5, 2023 | Jan 6, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −270 | $40.53 | $11K | 363.4Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −300 | $39.55 | $12K | 363.6Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −5,286 | $38.58 | $204K | 363.9Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −2,894 | $37.58 | $109K | 369.2Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −70 | $40.80 | $3K | 372.1Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −500 | $39.74 | $20K | 372.2Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −5,527 | $38.54 | $213K | 372.7Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| O'Brien PatrickCOO and General Counsel | Sale | −2,653 | $37.53 | $100K | 378.2Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −247 | $40.52 | $10K | 145.3Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −300 | $39.56 | $12K | 145.5Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −3,682 | $38.52 | $142K | 145.8Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −1,642 | $37.49 | $62K | 149.5Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −136 | $40.54 | $6K | 151.2Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −300 | $39.74 | $12K | 151.3Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −2,837 | $38.53 | $109K | 151.6Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Hamilton James C | Sale | −1,194 | $37.46 | $45K | 154.4Kdirect | Jan 3, 2023 | Jan 5, 2023 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −30.6K | $40.00 | $1.2M | 336.7Kdirect | Dec 29, 2022 | Dec 30, 2022 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −200 | $30.62 | $6K | 91.5Kdirect | Nov 21, 2022 | Nov 22, 2022 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −19.3K | $29.98 | $579K | 91.7Kdirect | Nov 21, 2022 | Nov 22, 2022 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −1,900 | $50.51 | $96K | 4.1Mdirect | Feb 11, 2022 | Feb 14, 2022 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −61.5K | $50.90 | $3.1M | 4.1Mdirect | Feb 11, 2022 | Feb 14, 2022 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −42.2K | $52.28 | $2.2M | 4.1Mdirect | Feb 11, 2022 | Feb 14, 2022 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −40.9K | $53.11 | $2.2M | 4.2Mdirect | Feb 11, 2022 | Feb 14, 2022 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −316 | $64.35 | $20K | 348.9Kdirect | Jan 5, 2022 | Jan 7, 2022 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −4,400 | $63.75 | $281K | 349.2Kdirect | Jan 5, 2022 | Jan 7, 2022 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −5,000 | $62.49 | $312K | 353.6Kdirect | Jan 5, 2022 | Jan 7, 2022 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −10.3K | $61.88 | $640K | 358.6Kdirect | Jan 5, 2022 | Jan 7, 2022 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −12.4K | $60.49 | $752K | 368.9Kdirect | Jan 5, 2022 | Jan 7, 2022 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −3,786 | $63.95 | $242K | 464.0Kdirect | Jan 5, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −3,778 | $63.17 | $239K | 467.8Kdirect | Jan 5, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −16.5K | $62.00 | $1.0M | 471.6Kdirect | Jan 5, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −15.9K | $60.50 | $962K | 488.1Kdirect | Jan 5, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −60 | $64.35 | $4K | 155.6Kdirect | Jan 5, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −700 | $63.68 | $45K | 155.7Kdirect | Jan 5, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −1,100 | $62.64 | $69K | 156.4Kdirect | Jan 5, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −2,100 | $61.84 | $130K | 157.5Kdirect | Jan 5, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −2,290 | $60.51 | $139K | 159.6Kdirect | Jan 5, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −500 | $69.38 | $35K | 161.9Kdirect | Jan 4, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −649 | $68.12 | $44K | 162.4Kdirect | Jan 4, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −802 | $67.39 | $54K | 163.0Kdirect | Jan 4, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −7,469 | $65.59 | $490K | 163.8Kdirect | Jan 4, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Hamilton James C | Sale | −9,955 | $64.89 | $646K | 171.3Kdirect | Jan 4, 2022 | Jan 6, 2022 | Form 4 ↗ |
| Waddill William D.Director | Sale | −272 | $66.25 | $18K | 25.8Kdirect | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| Waddill William D.Director | Sale | −2,128 | $65.01 | $138K | 26.0Kdirect | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| Waddill William D.Director | Sale | −2,100 | $64.23 | $135K | 28.1Kdirect | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −244 | $66.25 | $16K | 4,950direct | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −1,916 | $65.04 | $125K | 5,194direct | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −1,890 | $64.26 | $121K | 7,110direct | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| De Backer MarianneDirector | Sale | −272 | $66.25 | $18K | 17.0Kdirect | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| De Backer MarianneDirector | Sale | −1,984 | $65.01 | $129K | 17.3Kdirect | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| De Backer MarianneDirector | Sale | −2,244 | $64.25 | $144K | 19.3Kdirect | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| PERRY MICHAEL SDirector | Sale | −272 | $66.25 | $18K | 85.5Kdirect | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| PERRY MICHAEL SDirector | Sale | −1,600 | $65.12 | $104K | 85.8Kdirect | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| PERRY MICHAEL SDirector | Sale | −2,628 | $64.30 | $169K | 87.4Kdirect | Jan 3, 2022 | Jan 4, 2022 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Purchase | +655 | $66.37 | $43K | 109.9Kdirect | Dec 28, 2021 | Dec 29, 2021 | Form 4 ↗ |
| Ferrari MauroDirector | Sale | −3,400 | $66.82 | $227K | 36.6Kdirect | Dec 28, 2021 | Dec 29, 2021 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −6,989 | $70.19 | $491K | 3.2Mdirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −9,223 | $69.52 | $641K | 3.2Mdirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −3,074 | $68.20 | $210K | 3.2Mdirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −14.9K | $67.19 | $998K | 3.2Mdirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −25.9K | $66.28 | $1.7M | 3.3Mdirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −100 | $70.99 | $7K | 111.0Kdirect | Nov 19, 2021 | Nov 22, 2021 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −5,696 | $70.01 | $399K | 111.1Kdirect | Nov 19, 2021 | Nov 22, 2021 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −13.7K | $69.01 | $946K | 116.8Kdirect | Nov 19, 2021 | Nov 22, 2021 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −5,830 | $66.09 | $385K | 3.3Mdirect | Oct 22, 2021 | Oct 22, 2021 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −44.2K | $65.57 | $2.9M | 3.3Mdirect | Oct 22, 2021 | Oct 22, 2021 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −15.0K | $66.23 | $993K | 3.3Mdirect | Oct 20, 2021 | Oct 22, 2021 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −2,750 | $63.76 | $175K | 9,000direct | Sep 13, 2021 | Sep 14, 2021 | Form 4 ↗ |
| OLUKOTUN ADEOYE YDirector | Sale | −2,250 | $63.76 | $143K | 11.8Kdirect | Sep 13, 2021 | Sep 14, 2021 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −5,000 | $65.24 | $326K | 109.9Kdirect | Sep 9, 2021 | Sep 10, 2021 | Form 4 ↗ |
| De Backer MarianneDirector | Sale | −5,000 | $89.85 | $449K | 21.5Kdirect | Jun 24, 2021 | Jun 25, 2021 | Form 4 ↗ |
| Hassard JamesChief Commercial Officer | Sale | −3,625 | $89.22 | $323K | 105.8Kdirect | Jun 22, 2021 | Jun 24, 2021 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −4,500 | $89.21 | $401K | 114.9Kdirect | Jun 22, 2021 | Jun 24, 2021 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −1,125 | $88.73 | $100K | 13.9Kindirect | Feb 22, 2021 | Feb 24, 2021 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −5,436 | $89.66 | $487K | 293.4Kdirect | Feb 8, 2021 | Feb 10, 2021 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −45.3K | $88.88 | $4.0M | 298.8Kdirect | Feb 8, 2021 | Feb 10, 2021 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −31.3K | $88.08 | $2.8M | 344.2Kdirect | Feb 8, 2021 | Feb 10, 2021 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −7,961 | $86.72 | $690K | 375.4Kdirect | Feb 8, 2021 | Feb 10, 2021 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −3,000 | $83.28 | $250K | 12.5Kindirect | Jan 15, 2021 | Jan 19, 2021 | Form 4 ↗ |
| Hamilton James C | Sale | −3,814 | $81.82 | $312K | 126.3Kdirect | Jan 14, 2021 | Jan 15, 2021 | Form 4 ↗ |
| Hamilton James C | Sale | −6,186 | $80.97 | $501K | 130.1Kdirect | Jan 14, 2021 | Jan 15, 2021 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −1,441 | $81.00 | $117K | 444.0Kdirect | Jan 12, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −11.6K | $81.02 | $940K | 445.4Kdirect | Jan 11, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Hassard JamesChief Commercial Officer | Sale | −15.6K | $75.00 | $1.2M | 109.4Kdirect | Jan 7, 2021 | Jan 8, 2021 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −13.2K | $72.67 | $962K | 293.4Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −10.6K | $72.27 | $767K | 306.6Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| O'Brien PatrickGeneral Counsel | Sale | −1,142 | $70.78 | $81K | 317.2Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −25.2K | $72.63 | $1.8M | 457.0Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −4,359 | $71.77 | $313K | 482.2Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −1,100 | $70.75 | $78K | 486.6Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Hamilton James C | Sale | −14.7K | $72.67 | $1.1M | 136.3Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Hamilton James C | Sale | −3,967 | $72.05 | $286K | 151.0Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Hamilton James C | Sale | −700 | $70.89 | $50K | 154.9Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Hamilton James C | Sale | −1,925 | $73.93 | $142K | 155.6Kdirect | Jan 5, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Hamilton James C | Sale | −10.3K | $72.91 | $755K | 157.6Kdirect | Jan 5, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Hamilton James C | Sale | −3,300 | $72.19 | $238K | 167.9Kdirect | Jan 5, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Hamilton James C | Sale | −3,800 | $71.09 | $270K | 171.2Kdirect | Jan 5, 2021 | Jan 7, 2021 | Form 4 ↗ |
| PERRY MICHAEL SDirector | Sale | −4,000 | $76.09 | $304K | 90.0Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −4,000 | $76.08 | $304K | 119.4Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Waddill William D.Director | Sale | −3,750 | $76.08 | $285K | 30.3Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −500 | $79.59 | $40K | 15.0Kindirect | Dec 17, 2020 | Dec 18, 2020 | Form 4 ↗ |
| GIVEN DOUGLAS BDirector | Sale | −9,075 | $79.30 | $720K | 114.7Kdirect | Dec 17, 2020 | Dec 18, 2020 | Form 4 ↗ |
| Waddill William D.Director | Sale | −1,800 | $73.10 | $132K | 25.0Kdirect | Dec 10, 2020 | Dec 11, 2020 | Form 4 ↗ |
| Waddill William D.Director | Sale | −1,200 | $68.50 | $82K | 26.8Kdirect | Dec 10, 2020 | Dec 11, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −4,003 | $71.61 | $287K | 2.5Mdirect | Dec 9, 2020 | Dec 10, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −5,880 | $70.87 | $417K | 2.5Mdirect | Dec 9, 2020 | Dec 10, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −12.1K | $69.80 | $842K | 2.5Mdirect | Dec 9, 2020 | Dec 10, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −16.7K | $67.27 | $1.1M | 2.5Mdirect | Dec 9, 2020 | Dec 10, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −16.3K | $67.97 | $1.1M | 2.5Mdirect | Dec 8, 2020 | Dec 10, 2020 | Form 4 ↗ |
| Bradshaw CurtChief Scientific Officer | Sale | −15.6K | $68.73 | $1.1M | 0direct | Nov 20, 2020 | Nov 23, 2020 | Form 4 ↗ |
| Bradshaw CurtChief Scientific Officer | Sale | −15.6K | $69.39 | $1.1M | 15.6Kdirect | Nov 19, 2020 | Nov 23, 2020 | Form 4 ↗ |
| San Martin JavierChief Medical Officer | Sale | −19.5K | $69.39 | $1.4M | 130.5Kdirect | Nov 19, 2020 | Nov 20, 2020 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −17.7K | $69.86 | $1.2M | 427.7Kdirect | Nov 9, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −25.8K | $69.04 | $1.8M | 445.3Kdirect | Nov 9, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −12.3K | $58.57 | $719K | 2.5Mdirect | Oct 23, 2020 | Oct 23, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −87.7K | $58.16 | $5.1M | 2.5Mdirect | Oct 23, 2020 | Oct 23, 2020 | Form 4 ↗ |
| Myszkowski Kenneth AllenChief Financial Officer | Sale | −29.2K | $54.04 | $1.6M | 427.7Kdirect | Oct 20, 2020 | Oct 22, 2020 | Form 4 ↗ |
| Ferrari MauroDirector | Sale | −10.0K | $48.00 | $480K | 31.0Kdirect | Oct 9, 2020 | Oct 13, 2020 | Form 4 ↗ |
| De Backer MarianneDirector | Purchase | +500 | $50.00 | $25K | 17.5Kdirect | Oct 8, 2020 | Oct 26, 2020 | Form 4 ↗ |
| De Backer MarianneDirector | Purchase | +500 | $50.93 | $25K | 17.0Kdirect | Oct 8, 2020 | Oct 26, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −50.0K | $41.35 | $2.1M | 2.6Mdirect | Aug 13, 2020 | Aug 14, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −23 | $39.55 | $910 | 2.6Mdirect | Jun 25, 2020 | Jun 26, 2020 | Form 4 ↗ |
| Anzalone Christopher RichardChief Executive Officer · Director | Sale | −100.0K | $38.81 | $3.9M | 2.6Mdirect | Jun 25, 2020 | Jun 26, 2020 | Form 4 ↗ |
| De Backer MarianneDirector | Purchase | +500 | $31.33 | $16K | 16.5Kdirect | Jun 15, 2020 | Jun 24, 2020 | Form 4 ↗ |
| PERRY MICHAEL SDirector | Sale | −6,100 | $36.42 | $222K | 8,000direct | May 12, 2020 | May 13, 2020 | Form 4 ↗ |
| PERRY MICHAEL SDirector | Sale | −29.9K | $35.71 | $1.1M | 14.1Kdirect | May 12, 2020 | May 13, 2020 | Form 4 ↗ |
| Waddill William D.Director | Sale | −26.0K | $36.54 | $950K | 28.0Kdirect | May 11, 2020 | May 13, 2020 | Form 4 ↗ |
| GIVEN BRUCE DChief Operating Officer | Sale | −700 | $40.00 | $28K | 850.7Kdirect | Apr 28, 2020 | Apr 29, 2020 | Form 4 ↗ |
| GIVEN BRUCE DChief Operating Officer | Sale | −204 | $40.00 | $8K | 851.4Kdirect | Apr 28, 2020 | Apr 29, 2020 | Form 4 ↗ |
| GIVEN BRUCE DChief Operating Officer | Sale | −213 | $40.00 | $9K | 851.6Kdirect | Apr 28, 2020 | Apr 29, 2020 | Form 4 ↗ |
| GIVEN BRUCE DChief Operating Officer | Sale | −830 | $40.00 | $33K | 851.8Kdirect | Apr 28, 2020 | Apr 29, 2020 | Form 4 ↗ |
| GIVEN BRUCE DChief Operating Officer | Sale | −1,200 | $40.00 | $48K | 852.7Kdirect | Apr 28, 2020 | Apr 29, 2020 | Form 4 ↗ |
| GIVEN BRUCE DChief Operating Officer | Sale | −1,454 | $40.00 | $58K | 853.9Kdirect | Apr 28, 2020 | Apr 29, 2020 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →